Passenger Lymphocyte Syndrome in Pediatric Lung Transplantation: A Recipient With Previous Hematopoietic Stem Cell Transplantation
Pediatric Transplantation · 2026
DOI: 10.1111/petr.70256 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pediatric Transplantation, 2026. Verfasst von Nicholas Avdimiretz und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Respiratory Medicine, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Lung Transplantation, Hematopoietic Stem Cell Transplantation, Bronchiolitis Obliterans, Postoperative Complications. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
Background
Passenger lymphocyte syndrome (PLS) is a rare complication following solid organ transplantation (SOT) that has not been reported in pediatric lung transplantation. It consists of hemolysis by antibodies from donor B‐lymphocytes against recipient red blood cells (RBCs).
Methods
We report the case of a 12‐year‐old girl who received bilateral lung transplantation for bronchiolitis obliterans secondary to graft‐versus‐host disease. She had undergone allogeneic matched unrelated hematopoietic stem cell transplantation (HSCT) 6 years prior for myelodysplastic syndrome (MDS). Details around the PLS event are reported, with emphasis on novel considerations.
Results
Lung transplant was uneventful with minor ABO mismatch between donor (O+) and recipient (A+), with a negative crossmatch. There was an abrupt drop in hemoglobin from 10.8 g/dL on post‐operative day 11 to 6.6 g/dL on day 13. Direct antiglobulin test and markers for hemolysis were positive. Eluate test returned positive for anti‐A1 antibody, confirming PLS. Transfusion with donor‐type (O+) RBCs and IVIG were beneficial. A chimerism study revealed no recurrent MDS with fluorescence in situ hybridization revealing no circulating lung donor lymphocytes. The process was self‐limiting and hemoglobin recovered.
Conclusions
This case is the first to highlight PLS following lung transplantation in a child, and informs around post‐HSCT considerations. The novel use of chimerism studies and FISH can help elucidate the PLS course. It remains unclear if HSCT predisposes to PLS after subsequent SOT, although this may be due to sensitization to past RBC antigens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Pediatric Respiratory Medicine, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
- Division of Pediatric Hematology/Oncology, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
- Division of Pediatric Respirology, Pediatric Lung Transplantation, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Nicholas Avdimiretz
Zitieren
APA
Avdimiretz, N., Dror, Y., & Solomon, M. (2026). Passenger Lymphocyte Syndrome in Pediatric Lung Transplantation: A Recipient With Previous Hematopoietic Stem Cell Transplantation. Pediatric Transplantation. https://doi.org/10.1111/petr.70256
Vancouver
Avdimiretz N, Dror Y, Solomon M. Passenger Lymphocyte Syndrome in Pediatric Lung Transplantation: A Recipient With Previous Hematopoietic Stem Cell Transplantation. Pediatric Transplantation. 2026. doi:10.1111/petr.70256
BibTeX
@article{Avdimiretz2026,
author = {Avdimiretz, Nicholas and Dror, Yigal and Solomon, Melinda},
title = {Passenger Lymphocyte Syndrome in Pediatric Lung Transplantation: A Recipient With Previous Hematopoietic Stem Cell Transplantation},
journal = {Pediatric Transplantation},
year = {2026},
doi = {10.1111/petr.70256}
}
EUVIMED